Research Comparison
Adipotide vs Tirzepatide
A side-by-side research comparison of Adipotide and Tirzepatide drawn from DRPSHP' peptide database records.
Adipotide
Adipotide, also catalogued as prohibitin-TP01, is a designed two-part molecule rather than something found in nature. One half is a homing sequence, CKGGRAKDC, a cyclic nine-residue peptide closed by a disulfide bond, which was picked out of phage-display libraries because it accumulates in the vasculature of white fat. The other half is D-(KLAKLAK)2, a synthetic amphipathic chain built from D-amino acids that has been used as a pro-apoptotic payload in other conjugates. Experiments were carried out in obese mice and then in rhesus monkeys, where changes in kidney tubule function were noted. Human data are very scarce, and most publications trace back to the group that engineered it.
Tirzepatide
Two incretin receptors, one for GIP and one for GLP-1, are both switched on by tirzepatide, a synthetic 39-residue peptide. Its sequence is built mainly on GIP, carries aminoisobutyric acid at positions 2 and 13, and finishes with a tail that resembles exendin-4. Circulation time is extended by a 20-carbon fatty diacid joined to a lysine through a linker, which lets the molecule bind albumin. The compound has been examined in receptor pharmacology, rodent work and an extensive set of human clinical studies in metabolic disease. A continuing debate concerns the GIP half of the design, partly because rodent experiments have produced overlapping outcomes from both stimulating and blocking the GIP receptor.
Reading a comparison
A comparison places two records side by side; it does not merge them. Each description above is drawn from that compound's own record, and the two were not necessarily characterised by the same methods, at the same time, or to the same level of detail. Before comparing any attribute, it is worth establishing that both records describe the substance you think they describe — names are not identifiers, and two entries sharing a name can differ in salt form, stereochemistry or the convention used to state a mass. Where a figure carries no method beside it, the comparison is between two reported numbers rather than between two measurements.